. Surprisingly, DNA ligase I-deficient S. cerevisiae cdc9-1 cells that carry a PCNA K107R mutation are inviable, because they cannot activate a robust DDR. Furthermore, we show that ubiquitylation of PCNA in response to DNA ligase I deficiency is conserved in humans, yet the lysine residue that is modified remains to be determined. We propose that PCNA ubiquitylation provides a 'DNA damage code' that allows cells to categorize different types of defects that arise during DNA replication.
. These observations imply that S phase proceeds normally despite single-stranded breaks in nascent DNA, suggesting that cells may not be able to efficiently sense this type of DNA damage during S phase. To reinvestigate whether DNA ligase I is required for S phase progression, we analysed three different temperaturesensitive alleles of CDC9 (Supplementary Information, Figs S1a, b and S2a, b). One of these alleles was a thermo labile degron mutant 13 . Whereas DNA ligase I was not required for entry into S phase (Fig. 1b) , we found it to be necessary for release after a hydroxyurea block (Fig. 1c) , which was also true for two additional temperature sensitive alleles, cdc9-1 and cdc9-2 (ref. 15 ; Fig. 1d ). This result was surprising as earlier reports suggested that DNA ligase I-deficient cells could complete DNA synthesis without joining Okazaki fragments to one another 10, 11 . As expected, the cell-cycle delay in S phase was dependent on the DDR gene RAD9 (refs 10, 11) because cdc9-1 rad9Δ mutant cells progressed further than cdc9-1 cells ( Supplementary Information, Fig. S3a ). Importantly, however, the mediator of the replication checkpoint 1 (Mrc1) seemed to contribute as equally as Rad9 ( Supplementary Information, Fig. 3a, b) .
Mrc1 has been shown to have two roles, one in DNA replication and one in activating Rad53 after replication fork stalling, which results in exposure of single-stranded DNA 16 . Rad53 is a downstream target of the mitotic entry checkpoint gene MEC1, a homologue of the ATM/ATR checkpoint kinases in humans 17 . Complementation of cdc9-1 mrc1Δ double mutant cells with the S phase checkpoint-deficient mrc1 AQ allele 16 failed to induce cell-cycle arrest ( Supplementary Information, Fig. S3c ), suggesting that the S phase checkpoint, and not the replication function of Mrc1, is important to delay S phase progression. Furthermore, our finding that both Mrc1 and Rad9 are activated in cdc9-1 cells at the non-permissive temperature implies that the recognized DNA substrate has single-stranded DNA at stalled replication forks as well as physical damage, which may have arisen from the lack of Okazaki fragment ligation 12 .
Besides triggering a checkpoint response, certain types of DNA damage at replication forks have also been shown to cause ubiquitylation of PCNA 18 . PCNA can be either mono-or poly-ubiquitylated. Monoubiquitylation of PCNA triggers the error-prone repair pathway through translesion polymerases, whereas PCNA poly-ubiquitylation is needed for error-free repair 3, 19, 20 . Mono-ubiquitylation depends on Rad6 and Rad18 and is a pre-requisite for poly-ubiquitylation, which is mediated by the ubiquitin-conjugating complex Ubc13-Mms2 and Rad5 (ref. 3) . Interestingly, ubiquitin is linked through its Lys 63 residue in these polyubiquitin chains 3, 21 . To explore whether loss of DNA ligase I leads to PCNA ubiquitylation, we examined the status of PCNA in whole cell extracts. We used an antibody specific to yeast PCNA 22 , which showed several non-specific bands with undiluted extracts ( Supplementary Information, Fig. S4 ), but produced clean immunoblots with diluted extracts (Fig. 2a) . Both cdc9-1 and cdc9-2 mutant cell extracts showed a modified form of PCNA with a relative molecular mass of approximately 39,000 (M r 39K) when shifted to the non-permissive temperature (Fig. 2a) . Co-immunoprecipitation experiments with strains that expressed Myc-tagged ubiquitin 23, 24 revealed this 39K band to be ubiquitylated PCNA, which we did not observe when we mixed cell extracts with beads in the absence of antibodies (Fig. 2b) . Curiously, we observed a non-specific band slightly above the 49K marker, which was especially obvious in extracts from cdc9-1 cells. Unfortunately, our co-immunoprecipitation studies did not allow us to draw any conclusions about the nature of this band, although we could not exclude the possibility that it represented poly-ubiquitylated PCNA sticking nonspecifically to the beads. Therefore, we overexpressed different ubiquitin mutants, including a Ub G75,76A double mutant, specifically designed to interfere with mono-ubiquitylation. Another mutant carried substitutions in all seven lysines (Ub-KO) and was thus defective in forming poly-ubiquitin chains. Analysis of trichloroacetic acid-precipitated whole cell extracts confirmed that the 39K form of PCNA represented mono-ubiquitylated protein (Fig. 2c) . Furthermore, two forms of PCNA that represented polyubiquitylated protein (at ~52K and 76K), because they disappeared in cells overexpressing the Ub-KO mutant, were visible (Fig. 2d) . A distinct ladder of ubiquitylated PCNA with similar molecular weight distribution has also been reported previously 25 . Surprisingly, poly-ubiquitin chains on PCNA were not linked through Lys 63 (ref. 21 ), as they are in response to other forms of replication stress 3 , but rather through Lys 29 (Fig. 2d) . Based on this result, we predicted that at least some of the genes that are known to have a role in Lys 63-linked poly-ubiquitylation (RAD6, RAD18, MMS2, UBC13 and RAD5; ref.
3) are dispensable for the ubiquitylation of PCNA in cdc9-1 mutant cells. Indeed, whereas MMS2 and RAD5 were required for mono-as well as poly-ubiquitylation, UBC13 and RAD18 were not ( Fig. 3a; Supplementary Information, Fig. S5a) in cycling cells, steady-state levels of Ubc5 are low and are upregulated in stationary phase 7 . Ubc4 and 5 have previously been implicated in the degradation of unfolded proteins in yeast 7 , but not in PCNA ubiquitylation. When we deleted UBC4 from cdc9-1 mutant cells and performed a temperature-shift experiment, PCNA ubiquitylation was drastically reduced, whereas deletion of UBC5 had no effect ( Supplementary  Information, Fig. S5c ). Because we were unable to generate an ubc4Δ ubc5Δ double mutant in the cdc9-1 background, we attached a nuclear export sequence onto UBC4 in a cdc9-1 ubc5Δ strain. Again, this resulted in a 95% reduction of PCNA mono-ubiquitylation (Fig. 3b) . These results suggested to us that the nuclear fraction of Ubc4 cooperates with Mms2 and Rad5 to ubiquitylate PCNA in DNA ligase I-deficient cells.
To further discern the function of PCNA ubiquitylation in DNA ligase I-deficient yeast, we monitored cell-cycle progression upon release from G1 phase. Specifically, we compared cdc9-1 cells with cdc9-1 mms2Δ and cdc9-1 ubc13Δ double mutants. Consistent with our finding that UBC13 is not involved in the ubiquitylation of PCNA (Fig. 3a) , cdc9-1 ubc13Δ cells arrested in S phase, similarly to the cdc9-1 strain (Fig. 4a ). In contrast, cdc9-1 mms2Δ mutants, which failed to ubiquitylate PCNA at the non-permissive temperature (Fig. 3a) , readily progressed through S phase (Fig. 4a) . The observed lack of PCNA ubiquitylation and S phase arrest went hand-in-hand with the inability to phosphorylate Rad53 (Fig. 4b) . Importantly, this was not due to a general defect in checkpoint activation, as we detected Rad53 phosphorylation in all three strains after exposure to methyl methane sulfonate (MMS; Fig. 4c ).
To address whether mono-ubiquitylation is sufficient for Rad53 activation, we disrupted poly-ubiquitylation by overexpressing a ubiquitin mutant in which Lys 29 was substituted with arginine. This did not significantly affect Rad53 activation ( Supplementary Information,  Fig. S6a, b) . These results suggest that mono-rather than poly-ubiquitylation of PCNA is a prerequisite for checkpoint activation in DNA ligase I-deficient yeast cells.
Next, we set out to determine which lysine in PCNA was ubiquitylated. PCNA has a total of 18 lysines, nine of which are exposed and easily accessible 27 . We mutated these nine lysines (positions 107, 108, 117, 127, 164, 168, 183, 242 and 253). Wild-type or mutated forms of PCNA were introduced by a plasmid before the endogenous copy was deleted. When we monitored mono-ubiquitylation of PCNA in cdc9-1 cells after they were shifted to the non-permissive temperature, the only mutant that lacked the characteristic 39K band was pol30 K107R (Fig. 5a ). However, further examination revealed that this particular mutant had a second site suppressor mutation, which resulted in elevated DNA ligase I protein levels that were comparable to those in wild-type cells ( Supplementary  Information, Fig. S7a ). Moreover, the strain was no longer temperaturesensitive ( Supplementary Information, Fig. S7b ). We attempted several times to generate the double mutant, but these efforts remained unsuccessful, suggesting that the mutations were synthetically lethal.
To prove this point, we performed a plasmid shuffle assay. We introduced pol30 K107R into the chromosomal copy of PCNA in wildtype and cdc9-1 mutants, and expressed POL30 from a plasmid. Cells were forced to abandon the plasmid by re-streaking them onto 5-fluoroorotic acid-containing medium. Whereas CDC9 pol30 K107R cells were viable and formed colonies, cdc9-1 pol30 K107R mutants did not, indicating that Lys 107 of PCNA is essential in this background ( Supplementary Information, Fig. S8 ). This was further confirmed by tetrad analysis (data not shown), which seemingly yielded viable double mutants, but all of these strains had elevated DNA ligase I levels due to a second site suppressor mutation (data not shown). However, we were able to isolate a single double mutant in which Cdc9 levels were only slightly increased compared with cdc9-1 cells (cdc9-1* pol30 K107R ; Supplementary Information, Fig. S9a ). In fact, the double mutant retained its temperature sensitivity ( Supplementary Information,  Fig. S9b ) and failed to ubiquitylate PCNA under non-permissive conditions (Fig. 5b) . Importantly, PCNA ubiquitylation in response to MMS was still functional (Fig. 5c) .
It should be noted that we detected ubiquitylated and unmodified PCNA at an apparent ratio of approximately 1:1. However, it is not clear that the antibody binds these two forms of PCNA with equal affinity, and therefore it is difficult to make quantitative assessments. In addition, we interpreted the fact that we could readily generate cdc9-1 mms2Δ and cdc9-1 rad5Δ, but not cdc9-1 pol30 K107R double mutants to indicate that a redundant ubiquitylation pathway might exist that targets Lys 107 with low efficiency, thereby ensuring cell survival.
To confirm that Lys 107 is the target of PCNA ubiquitylation in DNA ligase I-deficient cells, we introduced the pol30 K107R mutation into cdc9 td cells. As expected, cdc9 td pol30 K107R double mutants retained viability, because CDC9 is expressed from an inducible copper promoter 13 . Under non-permissive conditions, the ratio of mono-ubiquitylated to unmodified PCNA in cdc9 td pol30 K107R cells resembled that in the DNA ligase I-proficient control strain, which carried the same mutation in POL30 (Fig. 5d) . The same was true for poly-ubiquitylated PCNA (Fig. 5e) . Furthermore, cdc9 td pol30 K107R cells failed to show robust Rad53 phosphorylation in the absence of DNA ligase I, whereas they showed Rad53 activation in response to MMS (Fig. 5f ). From these results, we conclude that ubiquitylation of PCNA at Lys 107 is a prerequisite for checkpoint activation in DNA ligase I-deficient yeast cells. This is in contrast to the previously described ubiquitylation of PCNA at Lys 164 in response to UV irradiation or DNA-alkylating agents 3 . Although exposure to UV light or DNA alkylating agents triggers both Rad53 phosphorylation and ubiquitylation of PCNA at Lys 164, these processes are thought to occur independently and belong to separate genetic pathways 28 . We demonstrate that this is not always the case, because PCNA ubiquitylation in response to DNA ligase I deficiency must occur before Rad53 can be fully activated.
It is worth noting that Lys 107 is conserved in S. pombe and C. elegans, but higher eukaryotes have a conserved lysine residue at position 110, raising the possibility that this PCNA ubiquitylation pathway is not only specific to S. cerevisiae ( Supplementary Information, Fig. S10 ). To test whether human cells depleted for DNA ligase I show PCNA modifications, we generated several U2OS cell lines expressing short hairpin RNAs (shRNAs) that interfere with DNA ligase I expression ( Supplementary  Information, Fig. S11 ). In the chromatin-bound protein fractions of these cells, we detected a slower migrating form of PCNA with the same mobility as mono-ubiquitylated PCNA induced by UV irradiation 29 ( Fig. 5g, upper panel; Supplementary Information, Fig. S11 ). In contrast, cells expressing control shRNA behaved like untreated U2OS cells (Fig. 5g, upper panel) . Importantly, when we analysed one representative DNA ligase I-specific shRNA clone side by side with a PCNA-or an ubiquitin-specific antibody, both antibodies recognized bands at exactly the same position, consistent with the notion that PCNA ubiquitylation in response to DNA ligase I deficiency is conserved in humans, although the particular lysine residue of PCNA that is ubiquitylated in these cells is still under investigation (Fig. 5g, upper and middle panel) . We also investigated S. cerevisiae rad27Δ and dna2-1 mutants, because both Rad27 and Dna2 have been implicated in lagging strand synthesis 30 . However, these mutants did not ubiquitylate PCNA ( Supplementary  Information, Fig. S12 ). This suggested that PCNA ubiquitylation at Lys 107 might be specific to DNA ligase I deficiency. In summary, whereas ubiquitylation at Lys 164 is responsible for the activation of translesion td -HA were detected with anti-Rad53 and anti-HA antibodies, respectively. In b, c, e and f, α-tubulin served as a loading control. In e and f, the asterisks indicate non-specific bands. (g) U2OS cells were either untreated or treated with 60 J per m 2 UV and collected 2 h later along with control shRNA (shCon) and DNA ligase I shRNA (shLIG1 A) cell lines. Chromatin fractions were prepared, fractionated on SDS-PAGE and analysed with the indicated antibodies. Samples on the PCNA and ubiquitin blots were analysed side by side. Unmodified PCNA served as a loading control for the PCNA blot and histone H3 served as a loading control for the ubiquitin blot. Ub, ubiquitin; Rad53-P, phosphorylated Rad53. synthesis, and is thus a result of DNA damage in the template strand, ubiquitylation of Lys 107 in DNA ligase I-deficient cells might act as a signal for damage of freshly synthesized, nascent DNA. Most importantly, our study demonstrates that the ubiquitylation of the different lysine residues of PCNA provides a DNA damage-specific code.
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Strains and plasmids.
All strains are isogenic derivatives of the W303-1a or SSL204 strain. A complete list of strains can be found in Supplementary  Information, Table 1 . The W303-1a strain carries the rad5-535 mutation (http:// wiki.yeastgenome.org/index.php/CommunityW303.html), whereas SSL204 derivatives (CDC9, cdc9-1, cdc9-2) harbour wild-type RAD5, which was confirmed by sequencing. SSL204 exhibits severe temperature sensitivity at 37 °C and therefore the temperature shift experiments were performed at 35 °C. To construct the cdc9 td strain, the first 510 base pairs of CDC9 were inserted into pPW66R (a gift from J. F. X. Diffley, Clare Hall Laboratories, UK) using HindIII restriction sites 13 . The resulting pPW66R-CDC9 plasmid was linearized with BclI and transformed into YKL83, which contains UBR1 under the control of the GAL1 promoter at the endogenous UBR1 locus 31 . To delete various genes (MRC1, RAD9, UBC4, UBC5, RAD6, RAD18, MMS2, UBC13 and RAD5) in SSL204 and SSL612, standard one-step PCR gene replacement was used 32 and correct integration was confirmed by sequencing. Two independent colonies of each strain were isolated.
The UCB4-NES-3HA fragment containing a nuclear export sequence (NES) 33 and three hemagglutinin (HA) tags was generated by PCR. This was inserted into the pRS404 plasmid (a gift from D. Koepp, University of Minnesota, MN, USA) using KpnI and SacI restriction sites. The resulting integration plasmid was linearized using BglII and transformed into two independent cdc9-1 ubc5Δ strains. Correct integration was confirmed by sequencing and immunoblotting with an anti-HA antibody(16B12, Covance). For the MRC1 complementation experiments, pAO138 and pMRC1 (gifts from S. J. Elledge, Harvard Medical School, MA, USA) were transformed into ABy287 (CDC9 mrc1Δ) and ABy293 (cdc9-1 mrc1Δ). pAO138 contains wild-type MRC1 expressed from its endogenous promoter and pMRC1 expresses a mrc1 mutant that has 17 putative SQ or TQ phosphorylation sites switched to AQ (mrc1 AQ mutant) and is also expressed from its endogenous promoter 16 . pRS316 served as the empty vector control. mrc1Δ rad9Δ cells were derived from a strain containing a high copy number plasmid expressing RNR1 from its endogenous promoter (a gift from D. J. Clarke, University of Minnesota, MN, USA) to maintain cell viability.
PCNA lysine mutants were generated using plasmid YCplac22-POL30 (a gift from S. Jentsch, Max Planck Institute of Biochemistry, Germany) 3 . YCplac22-POL30 expresses full-length PCNA from its endogenous promoter. Lysine to arginine substitutions in PCNA were introduced at positions 107, 108, 117, 168, 183 and 253 by QuikChange mutagenesis (Stratagene). Four other lysine to arginine mutations (K127R, K164R, K127/164R and K242R) used in this study were a gift from the Jentsch laboratory 3 . As described previously 32 , the endogenous POL30 gene was subsequently deleted by replacement with either a URA3 or LEU2 marker in SSL204 and YKL83 strains, respectively.
To determine the cell viability of the double mutant cdc9-1 pol30
K107R
, a plasmid expressing POL30 from its endogenous promoter (pRS316-POL30, a gift from D. M. Livingston, University of Minnesota, MN, USA) was first transformed into SSL204 (CDC9) and cdc9-1. The PCNA lysine K107R mutant was generated using plasmid pCH1572 (a gift from L. Prakash, University of Texas, TX, USA). The resulting Leu2.PCNA K107R PCR product was subsequently transformed into strains containing pRS316-POL30 plasmid. PCNA K107R mutation at the endogenous locus was confirmed by sequencing. Strains were streaked out onto SC-Ura plate and 5ʹ-FOA (2 mg ml -1 ) plates. All plates were incubated at 25 °C for 2-3 days. For immunoprecipitation of ubiquitylated PCNA, YEp105 plasmid, expressing a synthetic Myc-tagged ubiquitin gene from a copper-inducible promoter (a gift from M. Hochstrasser, Yale University, CT, USA) 23 was transformed into SSL204 (CDC9), SSL612 (cdc9-1) and SSL613 (cdc9-2) cells. For the expression of ubiquitin mutants carrying lysine to arginine substitutions at positions 6, 11, 27, 29, 33, 48 and 63, YEp105 was altered by QuikChange mutagenesis. The carboxy-terminal glycine to arginine mutations in ubiquitin at positions 75 and 76 were constructed in YEp105 by QuikChange mutagenesis.
Yeast culture conditions. Temperature shift experiments were carried out in yeast peptone dextrose (YPD), unless stated otherwise. For a typical temperature shift experiment, cells were grown to mid-log phase (OD 600 = 0.6) at 25 °C and then shifted to the restrictive temperature of 35 °C for 3 h or as indicated.
The degron strain, cdc9 td , was grown overnight at 28 °C in YP plus 2% raffinose and supplemented with 10 μM CuSO 4 to induce CDC9 gene expression. Copper sulfate was omitted when cells were shifted to 37 °C. To increase the efficiency of Cdc9 td degradation, Ubr1 was overexpressed from a galactose-inducible promoter in the presence of 2% galactose.
For all experiments in which PCNA or ubiquitin were expressed from a plasmid, two independent colonies of each strain were grown in synthetic complete medium lacking tryptophan. In ubiquitin-overexpressing strains, ubiquitin was induced over the time period of three generations by addition of 0.1 mM CuSO 4 at a low cell density (OD 600 = 0.1) as described previously 23 .
Co-immunoprecipitation.
Whole cell extracts from exponentially growing cells were prepared using glass beads as described previously 34 . A cocktail of freshly prepared protease inhibitors (pepstatin, leupeptin, benzamidine and phenylmethyl sulfonyl fluoride) and N-ethylmaleimide were used to preserve ubiquitylated proteins by inhibiting deubiquitylating enzymes 24 . For immunoprecipitation, 4 μg of anti-Myc antibody (9E11, Thermo scientific) was added to the extract for 2 h at 4 °C. PCNA was detected by western blotting with an anti-PCNA antibody (clone S871, a gift from Z. Zhang, Mayo Clinic, MN, USA) 22 .
Protein preparation and western blotting analysis. Total protein extracts were prepared from cycling yeast cultures using TCA precipitation 35 ( Supplementary  Information, Fig. S1b ) and proteins were detected by western blotting analysis. Cdc9 td -HA was detected with an anti-HA antibody (16B12, Covance), histone H3 was detected with an anti-histone H3 antibody (Abcam), endogenous Cdc9 was detected with an anti-Cdc9 antibody (gift from A. E. Tomkinson, University of Maryland, MD, USA) and endogenous Rad53 was detected with an anti-Rad53 antibody (gift from J. F. X. Diffley). α-Tubulin served as a loading control. In some experiments shown in Supplementary Information, Ponceau S staining of the nitrocellulose membrane before blotting served as a loading control.
Detection of PCNA ubiquitylation. Unmodified and mono-ubiquitylated PCNA were analysed by western blotting with an anti-yeast PCNA antibody (clone S871, a gift from Z. Zhang) 22 . To detect mono-ubiquitylation with the polyclonal S871 antibody, we diluted WCEs 20-fold. Poly-ubiquitylated PCNA was detected with the same antibody in undiluted, TCA-precipitated whole cell extracts. Please note that this antibody was not able to detect the 76 K poly-ubiquitylated form of PCNA in immunoprecipitated samples (Fig. 2b) .
Cell synchrony and FACS analysis. To arrest cells in G1, alpha-factor was added to a final concentration of either 50 ng ml -1 (bar1Δ cells) or 15 μg ml -1 (BAR1 cells). Cells were blocked in S phase with the addition of 200 mM hydroxyurea. For G2/M arrest, nocodazole was added to a final concentration of 10 μg ml -1 . Cell-cycle progression was monitored using flow cytometry as described previously 36 . DNA was stained with propidium iodide in case of YKL83 strains, whereas Sytox Green was used for all other strains. All FACS samples were analysed using a Becton Dickinson FACSCalibur.
MMS sensitivity. Cells were grown to mid-log phase (OD 600 = 0.5-0.6) at 25 °C for cdc9 strains and at 28 °C for YKL83 derived strains. Cells were then incubated with 0.02% MMS 3 at 30 °C for cdc9-1 strains and at 37 °C for YKL83 strains for the indicated time period. For YKL83 strains, 2% galactose was added for 30 min before shifting the cells to 37 °C. After each time point, sodium thiosulfate (10%) was added to the treated cells to inactivate the MMS. Yeast cells were pelleted, washed with distilled water and total protein was TCA-precipitated.
Generation of stable shRNA-expressing cell lines. U2OS cells were maintained in RPMI 1640 supplemented with 10% heat inactivated FBS and 1% penicillin/ streptomycin at 37 °C in 5% CO 2 (v/v). To generate stable DNA ligase I knockdown cell lines, DNA ligase I specific lentiviral shRNA plasmids and control shRNA were used, and were from Open Biosystems. The sequences were: shL-IG#15ʹ-TGCTGTTGACAGTGAGCGCGCTTTCACCTGCGAATACAAATAGT GAAGCCACAGATGTATTTGTATTCGCAGGTGAAAGCTTGCCTACTGCC TCGGA, shLIG#25ʹ-TGCTGTTGACAGTGAGCGACCTGTTTGTACCGGAAG CAAATAGTGAAGCCACAGATGTATTTGCTTCCGGTACAAACAGGCTG CCTACTGCCTCGGA-3ʹ. We also used a non-silencing control shRNA5ʹ-T-GCTGTTGACAGTGAGCGATCTCGCTTGGGCGAGAGTAAGTAGTGAA GCCACAGATGTACTTACTCTCGCCCAAGCGAGAGTGCCTACTGCCTC GGA-3ʹ. These vectors have been described previously 37 . Stable cell lines were nature cell biology constructed as described previously 38 . Briefly, U2OS cells were transfected with 10 μg of shRNA plasmid (control or ligase I) with Fugene (Roche) according to the manufacturer's instructions. 48 h later, cells were trypsinized and plated in media containing 2 μg ml -1 puromycin at different dilutions for colony formation. 12 days later, drug-resistant colonies were picked, expanded and screened by western blotting for DNA ligase I expression.
Chromatin fractionation. To obtain the chromatin fraction, cells from one 10 cm plate for each cell line was collected and chromatin fractions were prepared exactly as described previously 39 . Briefly, cells were extracted to release soluble proteins and nuclear (insoluble) proteins were pelleted. The nuclear pellet was then sonicated to release chromatin bound proteins. Proteins were fractionated on SDS polyacrylamide gels and analysed by western blotting. Anti-DNA ligase I-(1:1,000, Santa Cruz), anti-histone H3-(1:10,000, Abcam), anti-PCNA-(1:300, Labvision), anti-ubiquitin-(1:10,000, Millipore), and anti-tubulin antibodies (1:20,000, Sigma) were used in this study.
Mammalian cell lysates and western blotting. Cells were lysed with NETN (20 mM Tris-HCl at pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40 plus protease inhibitors) on ice and then rocked for 10 min at 4 °C. Crude cell lysates were then centrifuged at 21,000g for 10 min and cleared lysates were collected.
Samples were boiled in 2× Laemmli buffer and fractionated on SDS-PAGE. Membranes were blocked in 5% milk-TBST and then probed with antibodies as indicated. Figure S2 cdc9-td cells lack DNA ligase I at elevated temperatures. a, ABy021 (UBR1 CDC9), ABy010 (GAL-UBR1 CDC9), and ABy008 (GAL-UBR1 cdc9-td) cells were streaked onto complete medium containing either 2% glucose (Glu.) or 2% galactose (Gal.) as the sole carbon source. The plates were incubated for two days at 28°C or 37°C as noted. b, Asynchronous cultures of ABy010 (GAL-UBR1 CDC9) and ABy008 (GAL-UBR1 cdc9-td) were grown overnight at 28°C in YP plus raffinose medium supplemented with 10 µM CuSO 4 . At OD 600 = 0.6, the culture was split, centrifuged and resuspended in either YP (Glu.) or YP plus galactose (Gal.) and incubated at 37°C. Samples were collected at 1, 2 or 3 hours. Cdc9-td-HA and histone H3 were detected by immunoblotting with anti-HA (16B12, Covance) and anti-histone H3 (Abcam) antibodies, respectively. Ponceau S staining served as an additional loading control. c, DNA was isolated from ABy317 cells (GAL-UBR1 cdc9-td) grown asynchronously at 28°C. In parallel, cells were arrested in G1 with alpha-factor. Following arrest, cultures were released and shifted to 37°C in the presence of galactose. RIP mapping was performed at the replication origin ARS1 using the primer ARS1/630 as described previously 2 . The transition point (TP) maps between elements B1 and B2. Okazaki fragment initiation sites visible at 28°C but not at 37°C (in the absence of DNA ligase I) are indicated by O1, O2 and O3. Sequencing reactions were fractionated adjacent to the primer extension reactions on a 6% denaturing polyacrylamide gel.
Figure S3
Deletion of MRC1 or RAD9 abrogates the S phase arrest in cdc9 mutants. a, Asynchronous cultures of SSL204 (CDC9), SSL612 (cdc9-1), ABy296 (CDC9 rad9∆), ABy297 (cdc9-1 rad9∆), ABy287 (CDC9 mrc1∆) and ABy293 (cdc9-1 mrc1∆) were grown at 25°C and shifted to the restrictive temperature of 35°C for 1.5, 3 or 4.5 h. DNA was stained with Sytox Green and monitored using flow cytometry. b, Asynchronous cultures of ABy352 (CDC9 pRNR1), ABy353 (cdc9-1 pRNR1), ABy356 (CDC9 mrc1∆ rad9∆ pRNR1) and ABy357 (cdc9-1 mrc1∆ rad9∆ pRNR1) were grown at 25°C and shifted to the restrictive temperature of 35°C for the indicated times. DNA was stained with Sytox Green and monitored using flow cytometry. c, Asynchronous cultures of ABy343 (CDC9 mrc1∆ +vector), ABy344 (CDC9 mrc1∆ +mrc1 AQ ), ABy345 (CDC9 mrc1∆ +MRC1), ABy346 (cdc9-1 mrc1∆ + vector), ABy347 (cdc9-1 mrc1∆ +mrc1 AQ ), and ABy348 (cdc9-1 mrc1∆ +MRC1) were grown at 25°C and shifted to the restrictive temperature of 35°C for 3 h. DNA was stained with Sytox Green and monitored using flow cytometry. In a-c, the vertical line indicates a 2C DNA content.
Figure S4
Detection of robust PCNA signal in cdc9 mutants using a yeast specific PCNA antibody. Asynchronous cultures were grown at 25°C and shifted to 35°C for 3 h. Total protein was TCA-precipitated and PCNA was detected using a yeast specific PCNA antibody (S871) 3 . α-tubulin served as a loading control.
Figure S6
Mono-ubiquitination of PCNA in cdc9 mutants is sufficient for Rad53 activation. a, Asynchronous cultures of ABy350 (cdc9-1 CuMyc-Ub) and ABy485 (cdc9-1 Cu-Myc-Ub-K29R) were grown overnight at 25°C to a density of 0.6 at 600 nm. Cells were shifted to 35°C for 3 h in the presence of copper sulfate to induce expression of Myc-tagged ubiquitin. Samples were taken at the indicated times and total protein was TCA-precipitated.Rad53 was detected by Western blotting using an antiRad53 antibody. Ponceau S served as a loading control. b, Asynchronous cultures of ABy349 (CDC9 Cu-Myc-Ub), ABy350 (cdc9-1 Cu-Myc-Ub) and ABy485 (cdc9-1 Cu-Myc-Ub-K29R) were grown as described in a. Total protein was TCA-precipitated. Poly-ubiquitinated PCNA was detected by Western blot with a yeast specific anti-PCNA antibody (S871) 3 . The asterisks indicate nonspecific bands. Ponceau S staining served as a loading control.
Figure S7
A second site suppressor in ABy459 (cdc9-1 pol30∆ ppol30-K107R) results in elevated DNA ligase I levels and loss of temperature sensitivity. a, Asynchronous cultures of SSL204 (CDC9), SSL612 (cdc9-1), ABy459 (cdc9-1 pol30∆ ppol30-K107R) were shifted to 35°C for 90 and 180 min. DNA ligase I was detected in TCA-precipitated protein with an antiCdc9 antibody and α-tubulin served as a loading control. The asterisk denotes a degradation product. b, Cells were spotted in ten-fold serial dilutions on SCtrp plates and incubated at the indicated temperatures for 2 days.
Figure S8
A PCNA mutation at K107 in DNA ligase I deficient cells inhibits cell proliferation. Wild-type (CDC9) and DNA ligase I deficient cells (cdc9-1) either with or without pol30-K107R integrated at the endogenous PCNA locus, all expressing POL30 from a low copy number plasmid, were grown on SC-ura and FOA plates for 2-3 days at 25°C. Wild-type (CDC9) and DNA ligase I deficient cells (cdc9-1) carrying a URA3 disruption of the BAR1 gene served as controls. Figure S9 cdc9-1* pol30-K107R has slightly elevated DNA ligase I levels but still retains its temperature sensitivity. a, Cultures of SSL204 (CDC9), SSL612 (cdc9-1) and ABy782 (cdc9-1* pol30-K107R) were grown asynchronously at 25°C and total protein was TCA-precipitated. DNA ligase I was detected using anti-Cdc9 antibody and α-tubulin served as a loading control. The asterisk denotes a degradation product. b, Cultures of SSL204 (CDC9), ABy685 (CDC9 pol30-K107R), SSL612 (cdc9-1), ABy782 (cdc9-1* pol30-K107R) were spotted in ten-fold serial dilutions on YPD plates and incubated at the indicated temperatures for 2-3 days. Figure S12 PCNA ubiquitination does not occur in rad27∆ and dna2-1 mutants. Asynchronous cultures were grown at 25°C and shifted to the restrictive temperature of 35°C for 3 h. Total protein was TCA-precipitated and PCNA was detected by a yeast specific anti-PCNA antibody (S871) 3 . α-tubulin served as a loading control.
